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Complex between Peptostreptococcus magnus ProteinL
and a Human Antibody Reveals Structural Convergence
in the Interaction Modes of Fab Binding Proteins
tural comparison with two other bacterial proteins inter-
acting with the Fab heavy chain shows that PpL, struc-
turally homologous to streptococcal SpG domains,
shares with the latter a similar binding mode. These two
bacterial surface proteins interact with their respective
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2 Department of Biochemistry
Institute of Biomolecular Sciences Peptostreptococcus magnus protein L (PpL: whole pro-
tein L. PpL domain: individual domain of protein L) is aUniversity of Southampton
Bassett Crescent East cell wall-anchored protein able to interact with a large
repertoire of mammalian immunoglobulins (Ig) [1].Southampton SO16 7PX
United Kingdom Staphylococcus aureus protein A (SpA) [2] and strepto-
coccal protein G (SpG) [3] also share this property, al-3 Laboratory of Molecular Recognition
The Babraham Institute though they recognize different Ig regions. PpL is pres-
ent at the surface of about 10% of PeptostreptococcusBabraham, Cambridge CB2 4AT
United Kingdom magnus strains [4]. It is a 76–106 kDa protein containing
four or five highly homologous, consecutive extracellular4 The Randall Centre
King’s College London Ig binding domains (depending on the bacterial strain
from which it is isolated [5, 6]). The structure of PpLGuy’s Campus
London SE1 1UL domain B1 (76 amino acids) has been determined by
NMR spectroscopy [7]. The fold of this domain is similarUnited Kingdom
to that of the SpG Ig binding domains. It consists of a
 sheet composed of two pairs of anti-parallel  strands
and an  helix that lies on top of the sheet.Summary
PpL interacts with Ig light chains [1], notably with the
kappa light-chain variable region (VL) from humans andBackground: Peptostreptococcus magnus protein L
(PpL) is a multidomain, bacterial surface protein whose other mammals [8, 9]. When present on the bacterial
surface, PpL has been described as a virulence factorpresence correlates with virulence. It consists of up to
five homologous immunoglobulin binding domains that of bacterial vaginosis in different clinical specimens [4].
It has also been shown that PpL induces histamine re-interact with the variable (VL) regions of kappa light
chains found on two thirds of mammalian antibodies. lease by basophils and mast cells, presumably by cross-
linking IgE bound to Fc receptors [10, 11].
PpL and SpA single domains are targets for proteinResults: We refined the crystal structure of the complex
between a human antibody Fab fragment (2A2) and a engineering due to their ability to bind the variable re-
gions (Fv) of a large population of antibodies. Thissingle PpL domain (61 residues) to 2.7 A˚. The asymmet-
ric unit contains two Fab molecules sandwiching a single unique property makes them valuable tools in biotech-
nology for the purification and recognition of recombi-PpL domain, which contacts similar VL framework re-
gions of two light chains via independent interfaces. The nant single-chain (sc) Fv. Such engineered antibodies
are increasingly used in the optimization of specificityresidues contacted on VL are remote from the hypervari-
able loops. One PpL-V interface agrees with previous and affinity by phage display and other in vitro evolution-
ary mutagenesis techniques [12]. The structural charac-biochemical data, while the second is novel. Site-
directed mutagenesis and analytical-centrifugation terization of PpL and SpA binding properties is useful
for defining the spectrum of Fvs, which bind to thesestudies suggest that the two PpL binding sites have
markedly different affinities for VL. The PpL residues in domains, based on their sequences.
We report in this study the crystal structure of theboth interactions are well conserved among different
Peptostreptococcus magnus strains. The Fab contact human antibody Fab 2A2 complexed through its VL re-
gion to a PpL domain. The same Fab was the subject ofpositions identified in the complex explain the high
specificity of PpL for antibodies with kappa rather than a previous crystallographic study describing its complex
with a Staphylococcus aureus protein A (SpA) domain,lambda chains.
which binds to the antibody VH region [13]. Here, we
compare the location of these two Ig binding domainsConclusions: The PpL-Fab complex shows the first in-
teraction of a bacterial virulence factor with a Fab light on either side of the Fv region of Fab 2A2 in relation to
the antigen-combining site. Unexpectedly, we find thatchain outside the conventional combining site. Struc-
5 Correspondence: estura@cea.fr (E.A.S.) Key words: immunoglobulin binding proteins (IBP); antibody com-
plex; cell surface protein; X-ray structurejb.charbonnier@cea.fr (J.B.C.)
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there are two PpL-Fab interfaces, such that one PpL Of the amino acids in the PpL domain, 12, located
mainly on strand 2 and the  helix, are involved in thisdomain has two separate regions that can interact with
kappa light chains and is capable of binding two Fabs interaction (Figure 2). This interface is characterized by
six hydrogen bonds (Figure 1b, Table 1). Three are be-simultaneously. The two interfaces involve similar sites
on the VL domains. One of the PpL–Fab interfaces con- tween main-chain atoms located on PpL strand 2 and
on strand A from the first Fab; they thus join the  sheetsforms to previous biochemical data, while the second
is novel. Site-directed mutagenesis and analytical-cen- of the Fab and the protein L into a unique sheet through
a  zipper interaction.trifugation studies suggest that the two PpL combining
regions have markedly different affinities for VL. The high Heteronuclear NMR spectroscopy has been used for
mapping backbone positions of the PpL domain B1 [20]specificity of PpL for kappa (the largest mammalian VL
gene family), rather than lambda chains, is discussed in involved in the interaction with the VL region. Most posi-
tions identified for domain B1 are also implicated in thelight of the structure of the complex. We analyze the
sequence diversity of the PpL domains at positions in- first interface of domain C* described in the present
study. These backbone positions are on strand 2 andvolved in the interaction with VL regions and discuss
avidity effects reported between whole PpL and Ig. Fur- the  helix of the PpL domains. A minor discrepancy
with the NMR results concerns the loop between the thermore, by comparing the interactions of PpL and SpG
with VL and CH1, respectively, we note that at a structural helix and strand 3, which does not make any contact
with the Fab VL region in the crystal structure of thelevel, the Fab binding modes of these two bacterial
proteins show a degree of convergence. complex. This loop is poorly defined in the NMR struc-
ture, so the discrepancy can be attributed to a change
in mobility upon complexation.Results and Discussion
The first interface was subjected to site-directed mu-
tagenesis of PpL domain C*. A 23-fold drop in affinityThe First VL-PpL Interface
The asymmetric unit has one PpL domain and two Fab results from a Y53F substitution [21] as measured by
competitive ELISA. This decrease following the loss ofmolecules. The PpL domain is in close contact with the
VL region from both Fabs (Figure 1a). This stoichiometry the tyrosine hydroxyl is as expected on the basis of the
energy of a neutral hydrogen bond [22], consistent withwas unexpected because no previous studies raised
any evidence for one PpL domain being able to complex the loss of the interaction between the Tyr-53 hydroxyl
group and the Thr-L20 carbonyl group of the VL regionto two VL regions simultaneously [6, 14].
The first interface buries a total solvent-accessible (Table 1). Thus, the first interface explains the existing
data well.area of 1300 A˚2 with approximately equal contributions
from both molecules, as determined with a 1.4 A˚ radius
probe, and is remote from the Ig heavy chain. There is
The Second VL-PpL Interfaceno conformational change in the backbone of either
In the crystal, the single PpL domain is sandwichedpartner upon binding. The PpL domain C* used in this
between the VL regions of two 2A2 Fabs present in thestudy has 94% sequence identity with the C4 domain
asymmetric unit (Figure 1a). The second interaction bur-[15]. Its affinity for kappa chains is comparable (130 nM)
ies a total solvent-accessible area of 1400 A˚2, compara-to the one measured for PpL domain B1 [14, 15]. Domain
ble to other protein-protein complexes [23]. The PpLC* maintains the same three-dimensional structure as
domain C* has a different orientation in the two interac-PpL domain B1 determined by NMR [7], and the two
tions relative to the Fab  sheet. This second interactionstructures superpose with an rmsd of 1.31 A˚ over 59
involves 15 VL residues, located mainly on the  strandsresidues. The complexed PpL domain C* superposes
A and B (as in the first interface) with some participationwith an rmsd of 0.39 A˚ over 61 residues of the crystallo-
of strands D and E (Figure 1c). Out of the 15 residuesgraphic structure of free PpL domain C* (B.J.S., unpub-
from the VL region involved in this second interaction,lished data). Similarly, the variable region of the com-
10 are common to the first one. On the contrary, noneplexed Fabs superimposes with an rmsd of 0.6 A˚ over
of the PpL residues that contribute significantly to this215 residues with the free structure determined pre-
interface are involved in the first one. The 14 amino acidsviously [13].
from the PpL domain involved in this second interactionThe interaction with PpL involves 13 residues from
come mainly from strand 3 and from the  helix (Figurethe Fab (Figures 1b and 1c). Ten are located in frame-
2). Six hydrogen bonds and two salt bridges mediate thiswork region 1 (FR1). The others are Lys-L107 from the
interaction (Table 2), as compared to only six hydrogensegment connecting the VL to the CL region, Glu-L143
bonds for the first interface (Table 1). Although unex-from the CL region, and Arg-L24 from the CDR-L1 region
pected from biochemical studies, this second PpL-Fab[16] on strand B. However, this residue does not belong
interface buries an area too large to be a crystal contact.to the VL hypervariable loops according to the structural
Given that this interface buries a surface larger thandefinition of Chothia [17] or to the positions frequently
1400 A˚2, the probability that it is just a crystal contactidentified by the contact with antigens [18]. Compared
can be evaluated as only 2% [24]. Thus, we believe thatwith SpA, which binds to the variable region of the same
this interface has to be given serious attention.human antibody (Fab 2A2) [13], PpL is farther away from
What is the strength of this second interaction? Atthe center of the antigen binding site (23 A˚ compared
present, no definite answer can be given, but we haveto 16 A˚). Hence, like SpA, PpL binding should not affect
used mutagenesis to probe the relative contributions ofaccessibility to the antigen-combining site, as also sug-
gested by competition assays [19]. these two interfaces. First, we constructed the Y64W
P. magnus Protein L-Fab Interactions
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Figure 1. PpL domain C* Complexed with Human IgM Fab 2A2
(a) Ribbon representation of the 2 Fab:1 PpL domain complex present in the asymmetric unit. The PpL domain C* (red) is sandwiched between
two Fabs (blue and green). Light colors represent the light chains, and dark colors represent the heavy chains. Magenta highlights the CDR
loops, as defined by Chothia [17], and positions the Fab-PpL interfaces relative to the combining site. Pseudo 2-fold axis symmetry relates
the two Fabs, but both interfaces are not symmetrical.
(b) Stereoview of the 2Fo  Fc electron density map contoured at 1 at the first VL-PpL interface. The letter L precedes amino acids from the
Fab light chain. Green dotted lines depict the three hydrogen bonds between Fab and PpL main-chain atoms. The three other hydrogen
bonds are shown in magenta and involve at least one side-chain atom.
(c) Ribbon representation of the VL region of Fab that interacts with the PpL domain. Ten residues common to the first and second interfaces
are in yellow. Positions in pink are only involved in the first interface, and those in light green are implicated only in the second interface. All
figures were generated with MOLMOL [42] or TURBO-FRODO [43].
mutant of a PpL domain C* to have an efficient fluores- second interfaces. In the Y53F-Y64W mutant, the re-
placement of Tyr-53 by Phe disrupts the hydrogen bondcent probe so as to measure Kd by the stopped-flow
method [21]. Second, we constructed two double mu- between the tyrosine hydroxyl and the L20 carbonyl in
the first interface. Similarly, we chose the D55A-Y64Wtants, Y53F-Y64W [21] and D55A-Y64W (this study), with
the purpose of weakening, respectively, the first and mutant in order to disrupt the salt bridge between Asp-
Structure
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Figure 2. Alignment of the Amino Acid Sequences of the Different Ig Binding Domains from PpL
The PpL residues represented are only those visible in the crystal structure. Domain C* is the one used in this study. Domains C1 to C4 are
from PpL3316 strain [5], and domains B1 to B5 are from PpL312 strain [6]. PpL residues involved in the first interface with the Fab 2A2 are
highlighted in pink, and those involved in the second binding site are in green. With the exception of Arg-52 (yellow), there is no overlap
between the residues involved in each interaction. Core residues are in bold. Those involved in the second interface are mainly located on
the  helix and strand 3 and are well conserved among the different PpL domains. Of note is that one mutation (Gly-71 to Lys) may reinforce
or weaken this second interface. The amino acid sequence of SpG domain III is also shown with the residues involved in the interaction with
the Fab shown in pink, those interacting with the Fc in cyan, and those implicated in both interactions in yellow.
55 and Arg-L24 as well as the hydrogen bond with the tors, with the result being receptor activation [26]. By
analogy, in our study a single PpL domain contactsSer-L7 side chain in the second interface. These three
single PpL domain constructs are correctly folded, as similar surfaces on two VL regions and could bridge two
Igs anchored at the membrane of B cells. The biologicalindicated by far-UV CD spectroscopy (data not shown).
While the loss of a single hydrogen bond at the first relevance of this second interface and the potential mi-
togenic activity of a single PpL domain on B cells areinterface has a significant effect on the dissociation con-
stant of the VL-PpL domain C* complex, the disruption under investigation.
of the salt bridge and the hydrogen bond mediated by
Asp-55 of PpL at the second interface does not alter VL Specificity of the PpL Binding Interactionthe Kd of the complex (Table 3). This suggests that PpL has been reported to bind efficiently to VL regionsthe binding of single PpL domain C* is dominated by the of about two thirds of the human Ig repertoire and to
first interface and that the dissociation constant of the thus encompass mainly the 1, 3, and 4 subgroups
second is at least one order of magnitude larger than [8] but neither 2 nor any  subgroups. The PpL kappa
the first one. specificity observed for human antibodies extends to
Evidence supporting the existence on a single PpL various other mammalian species [9]. To analyze the
domain of two Fab-combining regions, differing in affini- structural determinants of this specificity, we have su-
ties by about two orders of magnitude, has been ob- perimposed on the 2A2 VL region the equivalent struc-tained recently by analytical-centrifugation studies tures found on different kappa and lambda subgroups.
(B.J.S. and R. Beavil, unpublished data). We observed that PpL binding ability is mostly concen-
This observation is reminiscent of the 1:2 stoichiome-
try described for the interaction between human growth
hormone and its receptor [25], where two different faces
Table 2. Hydrogen Bonds and Salt Bridges Involved in theof the hormone contact similar surfaces on two recep-
Second VL-PpL Interface
VL Region PpL Domain C* Distance (A˚)
Table 1. Hydrogen Bonds Involved in the First VL-PpL Interface Ser L-7 O O	1 Asp 55 2.9
Ser L-10 O O1 Thr 65 3.2VL Region PpL Domain C* Distance (A˚) Ser L-12 N O Ala 66 2.9
Ser L-12 O N Leu 68 2.6Ser L-9 N O Glu 38 2.8
Ser L-9 O N 40 Lys 3.1 Arg L-18 N O Gly 71 3.1
Arg L-24 N
1 O	1 Asp 55 2.7Ser L-10 O O1 Glu 38 2.9
Ser L-10 O N Glu 38 3.1 Lys L-107 N O	1 Asp 67 2.6
Lys L-107 N O Leu 68 2.9Ser L-12 N O Thr 36 2.7
Thr L-20 O O
 Tyr 53 2.6
Hydrogen bond and salt bridge distances were calculated with the
program CONTACTS [44] with a maximum distance cutoff of 3.4 A˚Hydrogen bond distances were calculated with the program
CONTACTS [44] with a maximum distance cutoff of 3.4 A˚ and defined and defined according to the criteria of McDonald and Thornton
[45].according to the criteria of McDonald and Thornton [45].
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domains and five B domains with the C* domain (FigureTable 3. Dissociation Constants between PpL Single Domain C*
2) shows that domain C1, which differs at 20 positionsand Human  Chain as Determined by Stopped-Flow
Fluorescence Measurements out of 61, is the most distant from domain C*. The differ-
ences on C1 are distributed all over the domain, withPpL Construct Kd (M) Comment
higher incidence on the  helix and strands 2, 3, and
Wild type 0.131
4. The other C domains have a higher degree of se-
Y64 W 0.172 Fluorescent probe
quence identity with C*. The B domains have from 10Y53F–Y64W 2.82 Hydrogen bond on interface 1 disrupted
to 17 well-distributed changes compared to C*.D55A–Y64W 0.145 Hydrogen bond and salt bridge
Structurally, a core of seven critical residues can beon interface 2 disrupted
identified. These residues are those largely buried upon1From Beckingham et al [14].
complex formation or those involved in hydrogen bonds:2From Beckingham et al [21].
Gln-35 to Lys-40 from strand 2 and Tyr-53 from helix
. These seven residues are strictly conserved in eight
out of the ten PpL domains (Figure 2). Domains C1 andtrated on the L5 to L12 segment of the VL region and B5 each have only one nondisruptive difference. Thethat the interaction is dependent on the main-chain con-
changes from Thr-36 to Asn in C1 and from Glu-38 toformation of this segment, on which conformation the
Thr in B5 could weaken the interaction but not disrupt
 zipper interaction also depends. Particularly important
it. Residue changes outside the structural core in do-are residues L8–L12, which bury more than 80% of their
mains C2 and C3 could result in a slightly lower affinity
total accessible area. The VL residues of this segment for  chains compared to that of domain C*. Residues
and at other positions of the first interface are well con-
49 and 52 from domain C* are, respectively, Glu and
served among the recognized V regions (Table 4). The Arg, which make an internal salt bridge in the middle of
main chain superimposes well onto VL structures of the  helix. In domains C2 and C3, these residues are
the 1, 3, and 4 subgroups (rmsd of 0.3–0.5 A˚ over the replaced, respectively, by Lys and Ala. This disrupts the
eight residues from L5 to L12). Most 2 subgroup se- salt bridge and places the Lys in close proximity to two
quences have a proline residue at position L12 that intro- Arg residues, and this further results in an unfavorable
duces major steric hindrance by pointing the Pro ring accumulation of positive charges.
toward the PpL domain. For the  subgroup, two obser- As is the case for the five SpA domains with respect
vations account well for the absent or weak binding to their interaction with VH region [13], most PpL domains
activity found for these chains. Firstly, the L5–L12 seg- should also conserve all their hydrogen bonding interac-
ment is one residue shorter, resulting in backbone con- tions. Thus, we would expect that all the PpL domains
formational differences, which may alter the  zipper would bind to the VL region in a similar way so that a
interaction (rmsd of 1–1.2 A˚ over the seven residues whole PpL would contain at least four Ig binding sites.
from L5 to L12). Secondly, due to the reduced size of The equivalence in binding between the domains is con-
this segment, a cavity is created around positions L7 sistent with previous studies on the binding properties
and L8. The Fab recognition mode developed by the of different PpL constructs. These studies show that
PpL domain is highly dependent on the backbone con- avidity increases with the number of Ig binding domains
formation, different from that of SpA, which relies more [6]. In fact, a four-domain PpL has an avidity 100-fold
on a side chain-specific recognition mode [13]. higher than the single domain, and a fifth Ig binding
domain does not improve avidity further [6]. By superim-
Avidity of Whole PpL for Immunoglobulins posing a PpL-Fab complex on each VL region of whole
PpL contains four or five highly homologous, consecu- IgG [27, 28], we can show that the distance between
tive extracellular Ig binding domains in tandem, de- the C terminus of a PpL domain bound to one Fab and
pending on the strain. At what level are the positions the N terminus of the other bound PpL ranges from
involved in the first interface conserved between the 60–120 A˚ depending on the Fab hinge angle. Four do-
mains (including their interdomain linkers of 16 aminodifferent domains? Sequence alignment of the four C
Table 4. Sequences of the Human VL Gene Families at the Positions Involved in the First Interface with PpL
VL Subgroup PpL Binding L5 L6 L7 L8 L9 L10 L11 L12 L13 L18 L20 L22 L24
1 (19)  T Q S P S S L S A R T T R
3 (7)  T Q S P A T L S L,V R T S R,G
4 (1)  T Q S P D S L A V R T N K
2 (9)  T Q S P L S L P,S V P S S R,K
1 (5)  T Q * P P S V,A S G,A.E R,K T S S,T
2 (5)  T Q * P P,R,A S V,A S G S T S T
3 (9)  T Q * P P S,A V S V T,M R T S,G,Q
4 (3)  T Q * P,S P,S S A S A S K T T
5 (3)  T Q * P P,A,S S L,S,H S A S R,S T T,M
The numbers in parentheses for each VL group indicate the numbers of human germ-line sequences reported in the V Base database (Medical
Research Council, Centre for Protein Engineering; http://www.mrc-cpe.cam.ac.uk/imt-doc/). Families that represent more than 10% of the
total genes are reported. Amino acids observed in fewer than 15% of functional germline human genes are not reported. Positions 6 and 7
are shown in italics, although they are not in direct contact with PpL to aid the structural alignment between  and  chains. The asterisks
(*) indicate missing residues. The PpL binding properties are taken from Nilson et al. [8].
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Figure 3. Comparison of SpG-CH1 and PpL-
VL Interactions
Orienting the SpG and PpL  sheets in an
analogous manner underscores the structural
similarities of both interactions. Strand 2 of
both domains interacts with, respectively, an
Fab VL (blue) or an Fab CH1 (green)  strand
(colored lines represent hydrogen bonds be-
tween main-chain atoms). In both cases, the
bacterial strand 2 forms a continuous 
sheet with the Fab through a  zipper inter-
action.
acids each) could span this distance, and this could chain/main-chain hydrogen bonds in the SpG-CH1 inter-
face [30] but only three hydrogen bonds in the PpL-VLexplain the strong avidity effect observed on Ig binding.
The same pattern of modular domains binding to Igs is first interface. The external strand A of the VL region
involved in the interaction presents a bulge due to pro-shared by SpA and SpG, which like PpL seem to have
evolved high avidity for Ig by cassette duplication to line at position L8 in the middle of the strand, and this
bulge shortens the  zipper. Although the SpG and PpLallow multiple attachments [29].
Although the Kd of the second interface may be sub- domains are clearly the result of divergent evolution [29],
they have maintained a common binding strategy forstantially higher than the first, we cannot exclude the
possibility that the second interface could be structur- interacting with the  strands from different Ig domains
(Figure 3) through a main-chain-to-main-chain hydrogenally important for PpL avidity. A PpL molecule bound to
Ig through the high-affinity site of one domain could use bonding network.
Like SpA, PpL domains target a wide repertoire ofthe low-affinity site from another domain to interact with
the Ig molecules when this would be sterically more human immunoglobulins. As none of those bacterial do-
mains interferes with antibody-antigen recognition, theyfavorable than interacting via the first interface.
Structural Convergence between the Fab Binding
Table 5. Summary of Crystallographic Analysis
Modes of SpG and PpL
Data collection1Streptococci and Peptostreptococci are found in the
same habitats, including the human intestinal and geni- Resolution (A˚) 20–2.6
Unique reflections 29,954tal tracts. Their cell surface proteins share many com-
Redundancy 4.66 (5.0)mon features, and it has been proposed that a transfer
I/ 11.4 (2.5)of gene fragments may have occurred between these
Rsym (%) 11.6 (48.6)two infective bacteria [29]. With only 15% sequence
Completeness (%) 95.2 (93.7)
identity, the Ig binding domains are the least homolo- Space group P212121
gous regions between these cell surface proteins. De- Unit cell parameter a  55.2 A˚, b  87.3 A˚, c  210.5 A˚
spite the low sequence identity, these domains share a
Molecular replacement
common fold, with an  helix packed against a four-
Resolution (A˚) 20–4.0stranded  sheet. The NMR and crystal structures of
Correlation coefficient (%) 61.4 (46.9)2both domains have shown that the main structural differ-
Refinementence is the orientation of the  helices [7, 30]. The helix
runs almost parallel to the  strand direction in the PpL Resolution (A˚) 20–2.7
 sheet, whereas in SpG it runs diagonally across the Rwork (%) 21.5
sheet. This arises from a difference in the loop between Rfree (%)3 27.8
Rmsdthe  helix and the strand 3, which is one residue
Bonds (A˚) 0.007shorter in PpL. Since this is the region of SpG that binds
Angles () 1.424to Fc, it may in part explain the absence of Fc binding
Averaged B factor (A˚2) 45.5
by PpL. Luzzati coordinates error (A˚) 0.34
The interaction of SpG with CH1 and that of the first Number of water molecules 112
interface of PpL with VL regions of Fab (Figure 3) share
Rwork and Rfree values in the last shell (2.75–2.7 A˚) are, respectively,similar features. Both domains bury equivalent surface 31.3% and 34.7%.
areas upon binding to the Fab and have two common 1Numbers in bracket give values for the highest resolution shell
structural features. Firstly, the same region of these two (2.68–2.6 A˚).
2Correlation coefficient for the next highest solution is indicated indomains is buried in the interactions since SpG also
bracket.interacts through its strand 2 [31]. Secondly, in both
3Value of Rwork calculated for 5% randomly chosen reflections notcases this strand extends a  sheet of the Fab through
included in the refinement.
a zipper interaction. This interaction involves five main-
P. magnus Protein L-Fab Interactions
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PpL domain C* used in the crystallization has 94% sequence identitymay be used to aid the crystallization of antigen-Fab
with the C4 domain from PpL (4 mutations over 61 amino acids)[32, 33] or membrane protein-Fv complexes [34]. We
and was produced by recombinant expression [15].suggest that these small protein domains should be
Crystals were grown by vapor diffusion at room temperature in
used in a combinatorial manner to increase the variety sitting drops by the mixture of a reservoir solution (13%–16% [wt/wt]
of possible crystal contacts that can be formed. This monomethyl polyethylene glycol (MPEG) 5000, 100 mM imidazole
malate [pH 8.5]) with an equal volume of protein solution (5 mg/would help to solve some problematic crystallization
ml) containing different Fab 2A2:PpL molar ratios. The ratio wascases. Knowledge of the structure of the PpL-Fab com-
optimized with the aid of streak seeding [37]. Interestingly, the com-plex will facilitate the engineering of PpL variants with
plex crystals grew at a pH that was at or above the upper limit forextended binding capacity, for example to encompass
the growth of unliganded Fab 2A2 crystals. This is different from
 chains and improve their utility as reagents for Ig de- the Fab 2A2-SpA complex crystallization, in which crystals grew
tection and purification. under conditions that were nearly identical to those for the unbound
Fab 2A2. Crystals for data collection were enlarged by macroseed-
ing [37].Biological Implications
For data collection, crystals were transferred into a solution con-
taining 50% reservoir solution and 50% cryo-solution (25%(wt/wt)
Several pathogenic bacteria present cell surface pro- MPEG 5,000, 25%(v/v) ethylene glycol, 9%(v/v) xylitol, 100 mM
teins with immunoglobulin binding properties that con- HEPES, pH 7.5). Data were recorded at 120K from a single crystal
fer on them an advantage during invasion and coloniza- on DW32 beamline at LURE synchrotron facility and processed us-
ing the HKL package [38]. The crystal belongs to the orthorhombiction of host tissues. Some of these bacterial proteins
space group P212121 with a  55.2 A˚, b  87.3 A˚ and c  210.5 A˚.interact with a wide proportion of the immunoglobulin
Statistics are summarized in Table 5.repertoire through interactions with constant regions of
Structure Determination
immunoglobulin that are highly conserved in sequence. We used the molecular replacement method to solve the crystal
Two bacterial proteins, Staphylococcus aureus protein structure with the program AMoRe [39] by using coordinates of Fab
2A2 (PDB code: 1DEE) [13]. The variable (VL-VH) and the constantA (SpA) and Peptostreptococcus magnus protein L
(CL-CH1) regions were used separately as search models for the(PpL), interact with a wide range of antibodies by tar-
corresponding parts of the Fab 2A2-PpL complex (Table 5).geting variable, rather than constant, regions of Fab.
After the initial refinement of this model, A-weighted 2Fo Fc andWe recently reported the crystal structure of an SpA Fo  Fc electron density maps were examined with the program O
domain in contact with the variable-heavy (VH) region of [40]. The difference maps show electron density for a single PpL
an Fab [13] and we now report the crystal structure of domain sandwiched between two Fab fragments. Both the NMR
structure of the B1 domain [7] and the crystal structure of the C*a PpL domain in complex with the variable-light (VL)
domain of PpL (B.J.S, unpublished) were fitted globally in the elec-region of the same Fab. Both bacterial domains interact
tron density maps with the best fit for the crystal structure. The 2with the framework part of these variable regions without
Fab:1 PpL model was refined within the 20–2.7 A˚ resolution range
contacting the hypervariable loops. The positions identi- with the program CNS [41] and was rebuilt in O [40]. Detectable
fied in both complexes account well for the wide reper- PpL domain C* residues range from Glu-20 to Ala-80 (see Figure 2
toire of immunoglobulins recognized by both bacterial for numbering). As already observed by NMR [7], the 19 amino
acid long N terminus is disordered and thus absent from the finaldomains. In contrast with SpA, which targets conserved
structure. Small loops from the CH1 region (H136 to H143 and H196residues of the VH external  sheet, PpL targets a portion
to H204) of both Fab molecules were poorly defined in maps andof the VL region that is not strictly conserved in sequence removed from the final structure. However, the VH and VL regions of
but that maintains a constant backbone conformation both Fabs, the PpL domain, and in particular the VL-PpL domain
among most VL regions encoded by  genes. interfaces are well defined in the electron density maps (Figure 1b).
Statistics for the structure determination are summarized in Table 5.A single domain of this multidomain protein manifests
MutagenesisPpL activity. The PpL domain appears to have two inde-
The Y64W PpL and the Y53F-Y64W PpL mutants were constructedpendent binding sites for VL, which interact with very with the primers and methods described previously [21]. The D55A-
similar areas on the light chain but with markedly differ- Y64W mutant was made by the mutation of residue 55 on the Y64W
ent affinities. The residues involved in the VL interaction template DNA by the use of the antisense primer 5 TGC TAA TAA
are well conserved among the different PpL domains. AGC TGC ATA TCT 3. The site of the mutation is shown in bold.
All mutations were confirmed by DNA sequencing with the Seque-The interaction of the single domain accounts well for
nase 2.2 DNA sequencing kit (United States Biochemical Corpora-two of the properties reported for the whole protein L.
tion). Kd values determined at pH 8 were obtained by stopped-flowFirstly, PpL exhibits an avidity effect for whole immuno-
fluorescence measurements as previously described [14].
globulin, and the overall position of a single bacterial
domain suggests that a whole PpL with up to five do- Acknowledgments
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Accession Numbers
Coordinates and structure factors have been deposited in the Pro-
tein Data Bank (accession code: 1HEZ).
Note Added in Proof
After we submitted this paper, Ulf Sjo¨bring informed us that his
laboratory conducted extensive site-directed mutagenesis to docu-
ment PpL domain folding in collaboration with D. Baker. These ex-
periments, in good agreement with our X-ray structure, gave strong
indications that there are two binding sites in protein L: one in the
2-alpha helix and another one in the 3 alpha helix (facing the
other way).
